{
  "url": "https://openlegislation.uk/eu-decision-2017-2201/annex-I",
  "json_url": "https://openlegislation.uk/eu-decision-2017-2201/annex-I.json",
  "legislation": "eudn/2017/2201",
  "legislation_title": "Commission Implementing Decision (EU) 2017/2201 of 27 November 2017 authorising the placing on the market of 2′-fucosyllactose produced with Escherichia coli strain BL21 as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2017) 7662) (Only the German text is authentic)",
  "legislation_url": "https://openlegislation.uk/eu-decision-2017-2201",
  "path": "annex/I",
  "kind": "annex",
  "number": "I",
  "heading": "SPECIFICATIONS OF 2′-FUCOSYLLACTOSE",
  "text": "Definition:\nChemical name\nα-L-fucopyranosyl-(1→2)-β-D-galactopyranosyl-(1→4)-D-glucopyranoside\nChemical formula\nC18H32O15\nMolecular mass\n488,44 Da\nCAS No.\n41263-94-9\nDescription: 2′-fucosyllactose powder produced with a genetically modified strain of Escherichia coli BL21 is a white to ivory powder that is derived from 2′-fucosyllactose liquid concentrate by spray drying. The 2′-fucosyllactose liquid concentrate is a colourless to slight yellow clear 45 % w/v ± 5 % w/v aqueous solution.",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eudn/2017/2201/annex/I",
    "retrieved_at": "2026-11-01T15:13:17.824661+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}